Ecoza, Spectazole, Ketoconazole HRA (econazole) is a small molecule pharmaceutical. Econazole was first approved as Ecoza on 1982-12-23. It is used to treat cutaneous candidiasis, mycoses, tinea pedis, and tinea versicolor in the USA. It has been approved in Europe to treat cushing syndrome. It is known to target transient receptor potential cation channel subfamily V member 5 and transient receptor potential cation channel subfamily M member 2. Econazole nitrate's patent is valid until 2031-08-08 (FDA).
|Trade Name||Ketoconazole HRA|
|Indication||cushing syndrome, cutaneous candidiasis, mycoses, tinea pedis, tinea versicolor|
|Drug Class||Systemic antifungals (miconazole type)|